Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".
(Updates from 10:45 a.m. ET with closing information.)
NEW YORK (
TheStreet) -- Here's what Jim Cramer had to say on
CNBC's "Squawk on the Street" Wednesday.
A new cholesterol drug from
(REGN) had very positive phase III results and Cramer said it's putting
(MRK) Zetia drug to shame. REGN jumped 6% to $17.22.
(KR) with a neutral rating. Cramer said he prefers
Whole Foods Market
(WFM). KR rose 1% to $41.87.
"Goldman Sachs blesses"
by reiterating it as a buy, Cramer said, adding that the last thing we heard about the company involved accounting issues. AMT was 3.2% higher at $77.12.
Deutsche Bank raised its price target on
. Even though the stock has quadrupled in value, it appears to still have upside, according to Cramer. LNG was up 3.5% on the day to $38.17.
Stanley Black & Decker
provided dismal guidance and had poor margins, said Cramer. "This is a disaster." SWK plummeted 14.3% to $76.75.
beat earnings estimates and raised its dividend. Cramer thinks CEO Miles White is going great things and likes the dividend. ABT jumped 6.5% to $35.90.
To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.
-- Written by Bret Kenwell in Petoskey, Mich.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts